<?xml version="1.0" encoding="UTF-8"?>
<ListBucketResult xmlns="http://s3.amazonaws.com/doc/2006-03-01/"><Name>euromrd-public</Name><Prefix></Prefix><Marker></Marker><MaxKeys>1000</MaxKeys><IsTruncated>false</IsTruncated><Contents><Key>20220307_Guidelines_Euro_MRD_participantship_ALL_section_final_79ffeb0c60.pdf</Key><LastModified>2022-03-11T14:35:23.000Z</LastModified><ETag>&#34;f53fa156bcf740e135981291ad7c7fea&#34;</ETag><Size>83870</Size><Owner><DisplayName>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</DisplayName><ID>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</ID></Owner><StorageClass>ONEZONE_IA</StorageClass></Contents><Contents><Key>20220307_Guidelines_Euro_MRD_participantship_NHL_section_final_ba8b45099f.pdf</Key><LastModified>2022-03-11T14:35:23.000Z</LastModified><ETag>&#34;665f7108dbf7079937360d4af5774722&#34;</ETag><Size>73421</Size><Owner><DisplayName>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</DisplayName><ID>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</ID></Owner><StorageClass>ONEZONE_IA</StorageClass></Contents><Contents><Key>20220307_Guidelines_Euro_MRD_participantship_Ph_ALL_section_final_04ccb5f0cc.pdf</Key><LastModified>2022-03-11T14:35:23.000Z</LastModified><ETag>&#34;75f76fd6a7ff2c7f44ff577784bfda38&#34;</ETag><Size>82393</Size><Owner><DisplayName>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</DisplayName><ID>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</ID></Owner><StorageClass>ONEZONE_IA</StorageClass></Contents><Contents><Key>20231003 Application form EuroMRD membership_ALL MLL Lymphoma section_New Format.docx</Key><LastModified>2023-10-16T16:48:18.000Z</LastModified><ETag>&#34;ccef918fdfd75fc6c6e69f83fee0e605&#34;</ETag><Size>123952</Size><Owner><DisplayName>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</DisplayName><ID>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</ID></Owner><StorageClass>ONEZONE_IA</StorageClass></Contents><Contents><Key>20231003 Application form EuroMRD membership_Ph-ALLSection_New Format.docx</Key><LastModified>2023-10-16T16:48:11.000Z</LastModified><ETag>&#34;fc96fb85cb1e60eccce2d0e23e4b0d2e&#34;</ETag><Size>117225</Size><Owner><DisplayName>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</DisplayName><ID>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</ID></Owner><StorageClass>ONEZONE_IA</StorageClass></Contents><Contents><Key>Disclaimer-EuroMRD.pdf</Key><LastModified>2021-10-28T15:21:03.000Z</LastModified><ETag>&#34;a31f9d8841efe77b94125eb25d937392&#34;</ETag><Size>95913</Size><Owner><DisplayName>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</DisplayName><ID>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</ID></Owner><StorageClass>ONEZONE_IA</StorageClass></Contents><Contents><Key>Guidelines_for_RQ-PCR_MRD_data_interpretation-Leukemia2007_ 21_604-611.pdf</Key><LastModified>2021-10-28T15:38:43.000Z</LastModified><ETag>&#34;689a02ba027e90b2b2a3dea28a3ea8a4&#34;</ETag><Size>417562</Size><Owner><DisplayName>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</DisplayName><ID>ee62aacd-6f1f-4c35-ae07-213c6901b8fc:ee62aacd-6f1f-4c35-ae07-213c6901b8fc</ID></Owner><StorageClass>ONEZONE_IA</StorageClass></Contents></ListBucketResult>